Bessemer Group Inc West Pharmaceutical Services Inc Transaction History

Bessemer Group Inc

$61.3 Billion
Q4 2024

A detailed history of Bessemer Group Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Bessemer Group Inc holds 748 shares of WST stock, worth $170,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

748

Previous 669 11.81%

Holding current value

$170,177

Previous $201,000 21.89%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$285.69 - $344.0 $22,569 - $27,176	79 Added 11.81%	748 $245,000
Q3 2024 Nov 12, 2024	BUY	$277.16 - $333.3 $6,929 - $8,332	25 Added 3.88%	669 $201,000
Q2 2024 Aug 13, 2024	SELL	$314.68 - $395.94 $94,089 - $118,386	-299 Reduced 31.71%	644 $213,000
Q1 2024 May 13, 2024	SELL	$338.27 - $413.0 $914,343 - $1.12 Million	-2,703 Reduced 74.14%	943 $373,000
Q4 2023 Feb 09, 2024	SELL	$318.29 - $392.21 $114,584 - $141,195	-360 Reduced 8.99%	3,646 $1.29 Million
Q3 2023 Nov 13, 2023	SELL	$354.9 - $412.41 $12,421 - $14,434	-35 Reduced 0.87%	4,006 $1.5 Million
Q2 2023 Aug 10, 2023	SELL	$334.63 - $382.47 $20,747 - $23,713	-62 Reduced 1.51%	4,041 $1.55 Million
Q1 2023 May 10, 2023	SELL	$232.5 - $346.47 $16,740 - $24,945	-72 Reduced 1.72%	4,103 $1.42 Million
Q4 2022 Feb 13, 2023	SELL	$209.34 - $261.61 $229,017 - $286,201	-1,094 Reduced 20.76%	4,175 $983,000
Q3 2022 Nov 09, 2022	SELL	$246.08 - $343.65 $492 - $687	-2 Reduced 0.04%	5,269 $1.3 Million
Q2 2022 Aug 10, 2022	SELL	$280.61 - $420.45 $134,131 - $200,975	-478 Reduced 8.31%	5,271 $1.59 Million
Q1 2022 May 12, 2022	BUY	$357.49 - $445.92 $425,055 - $530,198	1,189 Added 26.07%	5,749 $2.36 Million
Q4 2021 Jan 27, 2022	BUY	$402.25 - $471.34 $392,596 - $460,027	976 Added 27.23%	4,560 $2.14 Million
Q3 2021 Nov 12, 2021	SELL	$363.01 - $468.47 $295,127 - $380,866	-813 Reduced 18.49%	3,584 $1.52 Million
Q2 2021 Aug 06, 2021	BUY	$284.77 - $363.2 $130,139 - $165,982	457 Added 11.6%	4,397 $1.58 Million
Q1 2021 May 13, 2021	SELL	$257.29 - $307.53 $48.5 Million - $58 Million	-188,610 Reduced 97.95%	3,940 $1.11 Million
Q4 2020 Feb 09, 2021	BUY	$261.16 - $301.66 $67,640 - $78,129	259 Added 0.13%	192,550 $54.6 Million
Q3 2020 Nov 12, 2020	SELL	$224.99 - $288.02 $46.4 Million - $59.4 Million	-206,366 Reduced 51.77%	192,291 $52.9 Million
Q2 2020 Aug 05, 2020	SELL	$149.8 - $227.17 $10.3 Million - $15.6 Million	-68,878 Reduced 14.73%	398,657 $90.6 Million
Q1 2020 Apr 30, 2020	SELL	$128.96 - $174.76 $4.54 Million - $6.15 Million	-35,185 Reduced 7.0%	467,535 $71.2 Million
Q4 2019 Feb 04, 2020	SELL	$137.6 - $151.21 $17.3 Million - $19.1 Million	-126,028 Reduced 20.04%	502,720 $75.6 Million
Q3 2019 Nov 07, 2019	SELL	$121.41 - $150.02 $18.3 Million - $22.6 Million	-150,692 Reduced 19.33%	628,748 $89.2 Million
Q2 2019 Jul 19, 2019	BUY	$111.27 - $125.15 $252,582 - $284,090	2,270 Added 0.29%	779,440 $97.5 Million
Q1 2019 May 13, 2019	SELL	$94.53 - $110.2 $318,755 - $371,594	-3,372 Reduced 0.43%	777,170 $85.6 Million
Q4 2018 Feb 12, 2019	SELL	$93.0 - $123.98 $16.6 Million - $22.1 Million	-178,195 Reduced 18.59%	780,542 $76.5 Million
Q3 2018 Nov 06, 2018	BUY	$98.01 - $123.47 $776,337 - $978,005	7,921 Added 0.83%	958,737 $118 Million
Q2 2018 Jul 25, 2018	BUY	$83.32 - $101.88 $78.7 Million - $96.2 Million	944,000 Added 13849.77%	950,816 $94.4 Million
Q1 2018 May 10, 2018	SELL	$85.56 - $102.4 $21,218 - $25,395	-248 Reduced 3.51%	6,816 $602,000
Q4 2017 Jan 30, 2018	SELL	$91.65 - $101.65 $499,125 - $553,585	-5,446 Reduced 43.53%	7,064 $697,000
Q3 2017 Nov 03, 2017	BUY	$84.54 - $96.75 $1.06 Million - $1.21 Million	12,510	12,510 $1.2 Million

Others Institutions Holding WST

# of Institutions

816

Shares Held

65.5M

Call Options Held

244K

Put Options Held

424K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $16.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc West Pharmaceutical Services Inc Transaction History